Open access
3,595
Views
1
CrossRef citations to date
0
Altmetric
Research paper
Identification of a novel compound that simultaneously impairs the ubiquitin-proteasome system and autophagy
Tatiana A. Giovannuccia Department of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, Sweden
https://orcid.org/0000-0001-8978-6318View further author information
Florian A. Salomonsa Department of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, SwedenView further author information
, Henriette Stoya Department of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, SwedenView further author information
, Laura K. Herzoga Department of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, SwedenView further author information
, Shanshan Xua Department of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, SwedenView further author information
, Weixing Qianb Laboratories for Chemical Biology Umeå, Chemical Biology Consortium Sweden (CBCS), Umeå University, Umeå, SwedenView further author information
, Lara G. Merinoa Department of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, SwedenView further author information
, Maria E. Gierischa Department of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, SwedenView further author information
, Martin Haraldssonc Chemical Biology Consortium Sweden (CBCS), Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, SwedenView further author information
, Alf H. Lystadd Department of Molecular Medicine, Institute of Basic Medical Sciences and Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Blindern, Oslo, NorwayView further author information
, Hanna Uvellb Laboratories for Chemical Biology Umeå, Chemical Biology Consortium Sweden (CBCS), Umeå University, Umeå, SwedenView further author information
, Anne Simonsend Department of Molecular Medicine, Institute of Basic Medical Sciences and Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Blindern, Oslo, Norway;e Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo, Norway
https://orcid.org/0000-0003-4711-7057View further author information
Anna-Lena Gustavssonc Chemical Biology Consortium Sweden (CBCS), Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, SwedenView further author information
, Michaela Vallinc Chemical Biology Consortium Sweden (CBCS), Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, SwedenView further author information
& Nico P. Dantumaa Department of Cell and Molecular Biology (CMB), Karolinska Institutet, Stockholm, SwedenCorrespondence[email protected]
https://orcid.org/0000-0002-6090-4170View further author information
Pages 1486-1502
|
Received 17 May 2021, Accepted 28 Sep 2021, Published online: 05 Nov 2021
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.